These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 366231)
41. Pathophysiology of growth failure in chronic renal insufficiency. French CB; Genel M Kidney Int Suppl; 1986 Jul; 19():S59-64. PubMed ID: 3528627 [No Abstract] [Full Text] [Related]
42. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency. Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400 [TBL] [Abstract][Full Text] [Related]
43. Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding. Goldberg AC; Trivedi B; Delmez JA; Harter HR; Daughaday WH J Clin Endocrinol Metab; 1982 Dec; 55(6):1040-5. PubMed ID: 6752163 [No Abstract] [Full Text] [Related]
44. Effects of glucocorticoid on body growth and serum levels of somatomedin A in the rat. Asakawa K; Takano K; Kogawa M; Hasumi Y; Shizume K Acta Endocrinol (Copenh); 1982 Jun; 100(2):206-10. PubMed ID: 7113591 [TBL] [Abstract][Full Text] [Related]
45. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders. Bäckström M; Hall K; Sara V Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207 [TBL] [Abstract][Full Text] [Related]
46. [Transferrin, somatomedins and growth]. Donnadieu M; Schimpff RM; Garnier P; Martinez MJ; Chaussain JL; Job JC C R Seances Soc Biol Fil; 1980; 174(4):564-73. PubMed ID: 6449240 [TBL] [Abstract][Full Text] [Related]
47. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease. Takano K; Hizuka N; Shizume K; Hayashi N; Motoike Y; Obata H J Clin Endocrinol Metab; 1977 Oct; 45(4):828-32. PubMed ID: 914986 [TBL] [Abstract][Full Text] [Related]
48. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. Van Wyk JJ; Svoboda ME; Underwood LE J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184 [TBL] [Abstract][Full Text] [Related]
49. Assay of somatomedin C by cartridge extraction prior to radioimmunoassay with antiserum developed against synthetic somatomedin C. Kao PC; Tateishi K; Abboud CF; Zimmerman D; Randall RV; Li CH Ann Clin Lab Sci; 1988; 18(2):120-30. PubMed ID: 2454603 [TBL] [Abstract][Full Text] [Related]
50. In vivo and in vitro effect of liver on somatomedin generation. Minuto F; Barreca A; Del Monte P; Buffa C; Bevevino R; Montale F; Torre G; Giordano G Horm Metab Res; 1984 Dec; 16(12):663-6. PubMed ID: 6098543 [TBL] [Abstract][Full Text] [Related]
51. Radioreceptor-assayable somatomedins during pregnancy and their relationship to fetal growth. Sara VR; Gennser G; Persson PH J Dev Physiol; 1982 Jun; 4(3):187-93. PubMed ID: 6754800 [TBL] [Abstract][Full Text] [Related]
52. Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma. Horner JM; Liu F; Hintz RL J Clin Endocrinol Metab; 1978 Dec; 47(6):1287-95. PubMed ID: 263658 [TBL] [Abstract][Full Text] [Related]
54. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565 [TBL] [Abstract][Full Text] [Related]
55. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin. Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254 [No Abstract] [Full Text] [Related]
56. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Kirschner BS; Sutton MM Gastroenterology; 1986 Oct; 91(4):830-6. PubMed ID: 3743961 [TBL] [Abstract][Full Text] [Related]
57. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. Rosenfeld RG; Kemp SF; Hintz RL J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582 [No Abstract] [Full Text] [Related]
58. [Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption (author's transl)]. Kerpel-Fronius E; Kiss S; Kardos G; Gács G Monatsschr Kinderheilkd (1902); 1977 Aug; 125(8):783-6. PubMed ID: 904638 [TBL] [Abstract][Full Text] [Related]
59. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416 [TBL] [Abstract][Full Text] [Related]
60. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum. Moses AC; Nissley SP; Short PA; Rechler MM; White RM; Knight AB; Higa OZ Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3649-53. PubMed ID: 6932040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]